| Typicality: | 0.543 |
| Saliency: | 0.326 |
| on that date | 7 | temporal |
| upon request by competition management | 2 | cause |
| with immunodeficiency | 2 | other |
| vaccine → be administered to → person | 8 |
| vaccine → be administered by → person | 6 |
| vaccine → be administered to → human | 6 |
| vaccine → be administered to → subject | 4 |
| vaccine → be administered to → individual | 3 |
| vaccine → be administered to → participant | 3 |
| vaccine → be administered to → the person | 3 |
| negative | neutral | positive |
| 0.272 | 0.645 | 0.083 |
| Raw frequency | 33 |
| Normalized frequency | 0.326 |
| Modifier score | 0.975 |
| Perplexity | 206.252 |